Stereospecific blockade of alpha 2-adrenoceptors by (+)-butaclamol: implications for the characterization of dopamine receptors.
D000317:Adrenergic alpha-Antagonists; D000818:Animals; D002069:Butaclamol / Q000494:pharmacology*; D003000:Clonidine / Q000494:pharmacology; D003986:Dibenzocycloheptenes / Q000494:pharmacology*; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D010656:Phenylephrine / Q000037:antagonists & inhibitors; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000187:drug effects*; D013237:Stereoisomerism
D000317:Adrenergic alpha-Antagonists; D003986:Dibenzocycloheptenes; D011954:Receptors, Dopamine; D010656:Phenylephrine; D002069:Butaclamol; D003000:Clonidine